Evidence map›Paper›PMID 31150143›Full record

ArticleAlcoholism, clinical and experimental research2019

Early-Life Adversity and Blunted Stress Reactivity as Predictors of Alcohol and Drug use in Persons With COMT (rs4680) Val158Met Genotypes.

William R Lovallo, Andrew J Cohoon, Kristen H Sorocco, Andrea S Vincent, Ashley Acheson, Colin A Hodgkinson, David Goldman

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Catechol-Frontiers in genetics · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

William R LovalloVA Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Andrew J CohoonVA Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Kristen H SoroccoVA Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Andrea S VincentCognitive Science Research Center, University of Oklahoma, Norman, Oklahoma.
Ashley AchesonDepartment of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Colin A HodgkinsonLaboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, Maryland.
David GoldmanLaboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, Maryland.
University of Oklahoma Health Sciences Center · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institutes of Health · USUniversity of Arkansas for Medical Sciences · USUniversity of Oklahoma · USUniversity of Oklahoma Medical Center · US

Funding

Integrative genetics of behavior with high throughput technologiesZIAAA000301 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GOLDMAN, DAVID · 2009 to 2025
$68.6M
Psychophysiological Precursors of AlcoholismR01AA012207 · NIAAA · UNIV OF ARKANSAS FOR MED SCIS · PI ACHESON, ASHLEY, KOCHUNOV, PETER V. · 2001 to 2025
$9.0M
Neuroimaging in the Oklahoma Family Health Patterns ProjectI01CX000252 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI LOVALLO, WILLIAM R · 2011 to 2013
–
CSRD VA I01 CX000252NIAAA NIH HHS R01 AA012207U.S. Department of Veterans Affairs
6 · The paper itself

Abstract

backgroundRisk for alcoholism may be enhanced by exposure to early-life adversity (ELA) in persons with genetic vulnerabilities. We examined ELA in the presence of a common variant of the gene for the enzyme catechol-O-methyltransferase (COMT, Val158Met, rs4680) in relation to cortisol reactivity, the onset of early drinking, and experimentation with drugs.

methodsSaliva cortisol reactivity to speech and mental arithmetic stress was measured in 480 healthy young adults (23.5 years of age, 50% females) who experienced either 0, 1, or ≥ 2 forms of ELA during childhood and adolescence, provided information on use of alcohol and recreational drugs, and were genotyped for the Val158Met polymorphism.

resultsELA led to progressively smaller cortisol responses in the Met/Met and Val/Met allele groups but to progressively larger responses in Val homozygotes, F = 3.29, p = 0.011. ELA independently predicted earlier age at first drink, F = 14.2, p < 0.0001, with a larger effect in Met-allele carriers, F = 13.95, p < 0.00001, and a smaller effect in Val homozygotes, F = 4.14, p = 0.02. Similar effects were seen in recreational drug use. Cortisol reactivity was unrelated to drinking behavior or drug experimentation.

conclusionsELA leads to blunted stress reactivity and, independently, contributes to potentially risky drinking and drug-use behaviors in persons carrying 1 or 2 copies of the COMT 158Met allele. The results reinforce the impact of early experience on the stress axis and on risky behaviors, and they point to the 158Met allele as conveying a vulnerability to the early environment.

Indexed as

AdolescentAlcoholismAllelesCatechol O-MethyltransferaseChildChild AbuseFemaleGenotypeHumansHydrocortisoneIllicit DrugsMalePredictive Value of TestsStress, PsychologicalSubstance-Related DisordersYoung AdultCatechol O-MethyltransferaseCOMT protein, humanHydrocortisoneIllicit DrugsCatechol-O-MethyltransferaseCortisolDopamineDrinking BehaviorEarly-Life AdversityGenotypeStress

Identifiers

PMID31150143
PMCPMC6602827
OpenAlexW2947449568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.